We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Considers Neurontin Appeal of Canadian Class Action Suit
Pfizer Considers Neurontin Appeal of Canadian Class Action Suit
April 27, 2010
Pfizer is considering an appeal in a product liability suit over the epilepsy drug Neurontin after a Canadian court ruled the drugmaker can’t be held responsible for injuries suffered by patients who took a generic version of the drug, but the court allowed a class action against the company to proceed on separate claims.